Introducing OnePCR by G2M: A Fully Automated Detection System with Seamless Sample-to-Result Efficiency
G2M is excited to introduce OnePCR, a fully automated detection system that transforms point-of-care testing. With its innovative design, OnePCR offers a simplified sample-to-result process that eliminates the need for transferring samples between devices. Utilizing advanced cartridge technology, it combines nucleic acid extraction and real-time PCR into a single integrated instrument, reducing the risk of human error and positioning OnePCR as the most efficient and dependable testing solution available.
It is a simple “Sample In—result out” device that streamlines the workflow, delivering fast and accurate diagnostics in under 90 minutes. With unmatched efficiency and reliability, OnePCR is poised to be a game-changer in point-of-care testing.
Its Multi-Target Detection capability can identify up to 20 targets from a single sample, making it a highly versatile tool for comprehensive diagnostics. Equipped with a five-channel fluorescence system and an innovative circular cassette design, it ensures precise nucleic acid extraction and RT-PCR-based fluorescence detection. OnePCR operates independently with robotic liquid handling, completing each run in 30-70 minutes, providing rapid and reliable results.
The system uses a single-use, disposable sealed extraction and PCR cartridge to prevent contact with the instrument, environment, or carryover contamination. Built-in HEPA filters and UV light sterilization ensure efficient, contamination-free results. Its compact, lightweight, and ergonomic design is complemented by built-in intuitive automated reporting software for seamless operation.
OnePCR is equipped with QR code scanning on the cartridge for quick access to experiment protocols and features user-friendly, intuitive built-in software to enhance efficiency and convenience. Designed to be used beyond traditional lab environments, it can be operated by semi-skilled personnel with ease. The system includes pre-filled cartridges for both extraction and amplification, eliminating the need for manual liquid transfers, and streamlining the process even further. OnePCR utilizes magnetic bead-based extraction technology, ensuring efficient and reliable nucleic acid extraction. Additionally, it can connect to multiple independent modules, allowing for multi-sample analysis, further enhancing its capacity and flexibility for high-throughput testing.
About G2M
As a leading manufacturer of in vitro diagnostic (IVD) solutions, G2M is at the forefront of advancing healthcare through innovation. G2M has quickly established itself as a key player in the diagnostics industry, offering highly accurate, reliable, and competitively priced IVD solutions.
The launch of OnePCR, a state-of-the-art fully automated detection system, represents a major milestone in G2M’s growth. By integrating nucleic acid extraction and RT-PCR detection into a single, streamlined process, OnePCR simplifies diagnostics. Its user-friendly design, rapid turnaround time, and high sensitivity make it an essential tool for faster, more accurate point-of-care testing.
Beyond OnePCR, G2M’s product portfolio includes advanced offerings such as RT-PCR IVD kits, nucleic acid extraction solutions, and next-generation sequencing panels. With the introduction of OnePCR, G2M continues to push the boundaries of point-of-care testing, driving innovation and positioning itself as a trusted partner for healthcare providers.
